IP78-17: Prior 5-a-Reductase Inhibitor Exposure Associates with Enhanced ICI Benefit in Metastatic RCC: Multicentre Cohort with Single-Cell Immune Profiling

IP78-17: Prior 5-a-Reductase Inhibitor Exposure Associates with Enhanced ICI Benefit in Metastatic RCC: Multicentre Cohort with Single-Cell Immune Profiling

Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!